PRMT3 promotes tumorigenesis by methylating and stabilizing HIF1α in colorectal cancer
Abstract Abnormal angiogenesis occurs during the growth of solid tumors resulting in increased vascular permeability to fluids and metastatic cancer cells. Anti-angiogenesis therapy for solid tumors is effective in the treatment of cancer patients. However, the efficacy of anti-angiogenesis therapy...
Guardado en:
Autores principales: | Xin Zhang, Kexin Wang, Xingbo Feng, Jian Wang, Yali Chu, Chunmeng Jia, Qingsi He, Cheng Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/07436146f32043ab840f3eddf1e19e60 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PRMT1-mediated EZH2 methylation promotes breast cancer cell proliferation and tumorigenesis
por: Zhongwei Li, et al.
Publicado: (2021) -
Targeting SYK of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk/Hif1α and remodeling liver inflammatory environment
por: Xuejiao Chen, et al.
Publicado: (2021) -
Reciprocal regulation of LOXL2 and HIF1α drives the Warburg effect to support pancreatic cancer aggressiveness
por: Rongkun Li, et al.
Publicado: (2021) -
Correction: PRMT5 regulates cell pyroptosis by silencing CASP1 in multiple myeloma
por: Tian Xia, et al.
Publicado: (2021) -
SLC25A1 promotes tumor growth and survival by reprogramming energy metabolism in colorectal cancer
por: Ying Yang, et al.
Publicado: (2021)